SIRT7 regulates hepatocellular carcinoma response to therapy by altering the p53-dependent cell death pathway

Optimal therapeutic strategies for hepatocellular carcinoma (HCC) patients are still challenging due to the high recurrence rate after surgical resection and chemotherapy resistance. Growing evidence shows tha...

Source: Journal of Experimental and Clinical Cancer Research - June 13, 2019 Category: Cancer & Oncology Authors: Jie Zhao, Ann Wozniak, Abby Adams, Josiah Cox, Anusha Vittal, Jordan Voss, Brian Bridges, Steven A. Weinman and Zhuan Li Tags: Research Source Type: research